Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Braintree Laboratories

Clinical trials sponsored by Braintree Laboratories, explained in plain language.

New GERD drug shows safety over one year in large trial

Disease control Completed

This study tested the safety of a daily medication called BLI5100 in 400 adults with gastroesophageal reflux disease (GERD), including those with non-erosive reflux disease or healed erosive esophagitis. Participants took the drug once daily for up to 52 weeks. The main goal was …

Phase: PHASE3 • Sponsor: Braintree Laboratories • Aim: Disease control

Last updated May 22, 2026 13:51 UTC